19.1 Intracranial Pressure Monitoring, Cerebral Perfusion & Tiered ICP Management

Monro-Kellie Doctrine, Volume-Pressure Dynamics & Intracranial Compliance

The intracranial vault in adults is an inflexible, non-distensible osseous cavity with an internal volume of approximately $1400-1700\text{ mL}$. The Monro-Kellie doctrine states that this fixed intracranial volume is occupied by three non-compressible compartments:

$V_{\text{intracranial}} = V_{\text{brain}} (\approx 80\%,\ 1200-1400\text{ mL}) + V_{\text{blood}} (\approx 10\%,\ 150\text{ mL}) + V_{\text{CSF}} (\approx 10\%,\ 150\text{ mL})$

Because the total skull volume is constant, the expansion of an existing compartment (e.g., cerebral edema, hyperemia, or hydrocephalus) or the emergence of an abnormal space-occupying lesion (e.g., epidural or subdural hematoma, intracerebral hemorrhage, tumor, abscess) must be compensated for by an equal volumetric reduction of the remaining compartments. Otherwise, intracranial pressure (ICP) must rise.

Spatial Compensation and the Volume-Pressure Curve

In the initial stages of expanding mass lesions, ICP remains within normal limits ($5-15\text{ mmHg}$) through two primary compensatory displacement mechanisms:

1. Cerebrospinal Fluid (CSF) Translocation: CSF is rapidly displaced from the cerebral subarachnoid space and ventricular system downward into the distensible spinal subarachnoid thecal sac. Concurrently, CSF absorption through arachnoid granulations into the superior sagittal sinus accelerates.
2. Venous Blood Extrusion: Low-pressure cerebral venous blood is squeezed out of the cerebral veins and dural venous sinuses through the internal jugular veins into the systemic circulation.

Intracranial Pressure (mmHg)
  ^
100|
   |                                    / (Terminal Decompensation)
 80|                                   /
   |                                  /   Elastance Breakpoint
 60|                                 /
   |                                /
 40|                               /  <-- ICP > 22 mmHg (BTF Threshold)
   |                     _________/ 
 20|         ___________/
   |________/ (Compensated Phase)
  0+----------------------------------------------------> Mass Volume (mL)

Once these spatial buffering reserves are exhausted—typically after $100-150\text{ mL}$ of compensatory displacement—the intracranial volume-pressure curve reaches its critical elastance breakpoint ($E = \Delta P / \Delta V$). At this steep inflection point, intracranial compliance ($C = \Delta V / \Delta P$) approaches zero. Consequently, tiny additions of volume ($1-2\text{ mL}$ of hematoma growth or tissue edema) produce exponential, catastrophic spikes in ICP, resulting in microvascular collapse, acute cerebral ischemia, and fatal brainstem herniation.

Normal resting ICP in healthy supine adults ranges between $5\text{ and }15\text{ mmHg}$. Pathological intracranial hypertension is defined as sustained ICP $> 20\text{ mmHg}$. The Brain Trauma Foundation (BTF 4th Edition) establishes an evidence-based clinical treatment threshold of $\text{ICP} > 22\text{ mmHg}$, as sustained pressures above this level correlate independently with increased mortality and poor functional recovery.

---

Cerebral Blood Flow, Autoregulation & Cerebral Perfusion Pressure (CPP)

Normal cerebral blood flow ($CBF$) is tightly regulated at approximately $50\text{ mL/100 g brain tissue/min}$, consuming roughly $20\%$ of resting total-body oxygen despite the brain accounting for only $2\%$ of total body mass. The cerebral metabolic rate of oxygen consumption ($CMRO_2$) averages $3.0-3.5\text{ mL } O_2\text{/100 g/min}$:

• $CBF < 20-25\text{ mL/100 g/min}$: Electrographic silence on EEG, loss of synaptic activity, and progressive clinical neurological deficits.
• $CBF < 10-12\text{ mL/100 g/min}$: Failure of ATP-dependent $Na^+/K^+$ ATPase pumps, cytotoxic calcium influx, irreversible cell membrane depolarization, and neuronal necrosis (cerebral infarction).

Cerebral Perfusion Pressure Calculation and Autoregulatory Limits

Cerebral Perfusion Pressure (CPP) represents the net pressure driving blood across the cerebral capillary beds. It is calculated as the difference between systemic Mean Arterial Pressure ($MAP$) and Intracranial Pressure ($ICP$):

$CPP = MAP - ICP$

In the uninjured brain, cerebral autoregulation dynamically adjusts cerebral arteriolar caliber (myogenic response) to preserve a constant $CBF$ across CPP ranges between $50\text{ and }150\text{ mmHg}$ (or MAP $60-160\text{ mmHg}$):

• When CPP drops, cerebral precapillary resistance arterioles dilate to maintain volumetric flow.
• When CPP rises, arterioles constrict to protect fragile cerebral microvessels from hydrostatic rupture and hyperperfusion vasogenic edema.

In traumatic brain injury, acute ischemic stroke, subarachnoid hemorrhage, or severe intracranial hypertension, autoregulation is frequently disrupted or abolished. The cerebral circulation becomes "pressure-passive"—meaning $CBF$ fluctuates linearly with systemic blood pressure. Under pressure-passive conditions, arterial hypotension precipitates immediate cerebral ischemia, while arterial hypertension exacerbates vasogenic cerebral edema and intracranial hypertension.

Guideline-Directed CPP Targets

The Brain Trauma Foundation guidelines recommend a target CPP of $60\text{ to }70\text{ mmHg}$ in patients with severe brain injury:

• $CPP < 60\text{ mmHg}$: Substantially increases the risk of secondary cerebral ischemia and cellular death. Hypotension (defined as systolic blood pressure $< 90-100\text{ mmHg}$) is an independent predictor of doubled mortality in severe TBI.
• $CPP > 70\text{ mmHg}$: Aggressive pharmacologic elevation of CPP above $70\text{ mmHg}$ using excessive intravenous fluid boluses and high-dose vasopressor infusions does not improve neurological outcomes. Instead, randomized trials demonstrate that driving CPP $> 70\text{ mmHg}$ produces a five-fold increase in Acute Respiratory Distress Syndrome (ARDS) due to hydrostatic capillary leak.

---

Invasive ICP Monitoring: Indications and Modalities

Clinical Indications for Invasive Monitoring

According to the Brain Trauma Foundation guidelines, invasive ICP monitoring is indicated in:

1. Patients with severe Traumatic Brain Injury (GCS $3-8$ post-resuscitation) who demonstrate an abnormal admission non-contrast head CT (showing hematomas, contusions, cerebral swelling, herniation, or compressed/effaced basal cisterns).
2. Patients with severe TBI (GCS $3-8$) with a normal head CT if two or more of the following adverse features are present on admission:
   • Age $> 40\text{ years}$
   • Unilateral or bilateral decerebrate or decorticate motor posturing
   • Systolic blood pressure $< 90\text{ mmHg}$
3. Selected non-traumatic neurocritical conditions: Poor-grade aneurysmal subarachnoid hemorrhage (Hunt and Hess 3-5), large intracerebral hemorrhage with intraventricular extension and hydrocephalus, massive ischemic stroke with malignant cerebral edema, and acute liver failure with Grade 3-4 hepatic encephalopathy undergoing evaluation for liver transplantation.

Monitoring Modalities: EVD vs. Intraparenchymal Microtransducer

---

ICP Waveform Morphology, Compliance & Lundberg Waves

Pulse Waveform Morphology

The normal pulsatile ICP waveform is synchronized with each cardiac cycle and comprises three distinct, sequential peaks:

Pressure (mmHg)
  ^
  |        P1 (Percussion Wave)
  |         /\
  |        /  \    P2 (Tidal Wave)
  |       /    \    /\
  |      /      \  /  \   P3 (Dicrotic Wave)
  |     /        \/    \   /\
  |    /                \_/  \__
  +-------------------------------------> Time
      Normal Compliance: P1 > P2 > P3

1. P1 (Percussion Wave): Originates from systemic arterial pulsations transmitted from the choroid plexus into the ventricular fluid column during ventricular systole. It exhibits a steep upstroke and constant amplitude.
2. P2 (Tidal Wave): Represents the intracranial elastance and rebound of cerebral tissue against the rigid cranial vault. Under normal intracranial compliance, brain tissue readily absorbs the pulse, keeping $P_2$ significantly shorter than $P_1$.
3. P3 (Dicrotic Wave): Corresponds to aortic valve closure (dicrotic notch) and retrograde jugular venous pulsation.

• Normal Intracranial Compliance: Manifests as a descending staircase pattern: $P_1 > P_2 > P_3$.
• Compromised Intracranial Compliance (High Elastance): As spatial buffering reserves are exhausted, the brain cannot absorb systolic expansion. The tidal wave elevates progressively until $P_2 > P_1$, producing a rounded, pyramidal waveform. Elevation of $P_2$ above $P_1$ is a definitive sign of exhausted intracranial compliance, serving as an early warning of impending herniation even before mean numeric ICP crosses $22\text{ mmHg}$.

Lundberg Pathological ICP Waves

In 1960, Nils Lundberg classified spontaneous ICP fluctuations into three clinical patterns:

---

Tiered Protocolized ICP Management

Management of intracranial hypertension follows a structured, step-wise tiered escalation framework established by the Neurocritical Care Society and Brain Trauma Foundation. Progression to higher tiers occurs only when lower-tier interventions fail to control ICP below $22\text{ mmHg}$ or CPP between $60-70\text{ mmHg}$.

                      [TIER 3: Refractory ICP Rescue]
             Pentobarbital Coma | Hypothermia | Decompressive Craniectomy
                                     ^
                                     |
                      [TIER 2: Second-Line Interventions]
       Neuromuscular Blockade | Temporary Hyperventilation (PaCO2 30-35) | MAP Optimization
                                     ^
                                     |
                      [TIER 1: First-Line Targeted Therapy]
         EVD CSF Drainage | Osmotherapy (3% NaCl or Mannitol) | Repeat Imaging
                                     ^
                                     |
                      [TIER 0: Baseline Neuroprotection Bundle]
 HOB 30° | Midline Head | Normothermia (36-37.5°C) | Light Sedation/Analgesia | PaCO2 35-40 | Euvolemia

Tier 0: Foundational Neuroprotection (Applied to All At-Risk Patients)

• Positioning: Elevate head of bed to $30^\circ$ to enhance cerebral venous drainage via the internal jugular veins. Ensure head and neck remain strictly midline; avoid tight cervical collars, endotracheal tube ties, or neck rotation that compresses jugular venous return.
• Normothermia: Maintain core body temperature strictly between $36.0^\circ\text{C}$ and $37.5^\circ\text{C}$ with scheduled antipyretics and advanced surface or intravascular targeted temperature management (TTM). Hyperthermia exponentially increases $CMRO_2$, cerebral blood volume, and ICP.
• Analgesia and Sedation: Administer titratable short-acting agents (fentanyl, propofol) to control pain, coughing, agitation, and patient-ventilator dyssynchrony, which spike intrathoracic and intracranial pressures.
• Ventilation: Maintain strict normocapnia with $\text{PaCO}_2\ 35-40\text{ mmHg}$ and normoxia with $\text{PaO}_2 \ge 80-100\text{ mmHg}$ (or $\text{SpO}_2 \ge 94\%$).
• Fluid Balance: Maintain euvolemia using isotonic crystalloids (0.9% normal saline or Plasmalyte). Strictly avoid hypotonic solutions (e.g., 0.45% saline, lactated Ringer's, D5W), which lower serum osmolality and exacerbate cerebral edema.
• Seizure Prophylaxis: Give phenytoin (the agent studied and supported by the Brain Trauma Foundation guideline) or levetiracetam (widely used, with similar efficacy in observational data) for 7 days after severe TBI to reduce early post-traumatic seizures; prophylaxis does not prevent late epilepsy.

Tier 1: First-Line Targeted Therapies (Sustained ICP > 22 mmHg)

1. Cerebrospinal Fluid Drainage via EVD:
   • Open the EVD to drain CSF at $10-15\text{ cmH}_2\text{O}$ above the tragus.
   • Drain continuously or intermittently ($5-10\text{ mL}$ aliquots) to decompress the ventricular space.
2. Osmotherapy: Hypertonic Saline vs. Mannitol:
   • Hypertonic Saline (3% NaCl): Administer a bolus of about $250\text{ mL}$ IV over 15-30 minutes (about $3\text{--}5\text{ mL/kg}$), or $30\text{ mL}$ of $23.4\%$ NaCl over 10-20 minutes via central venous catheter for acute herniation crises. Titrate continuous 3% infusion to maintain serum sodium between $145\text{ and }155\text{ mEq/L}$ and serum osmolality $< 360\text{ mOsm/kg}$.
     • Advantages: Draws parenchymal free water across an intact blood-brain barrier without inducing osmotic diuresis; expands intravascular volume, stabilizes MAP, and improves microvascular rheology.
   • Mannitol (20% solution): Administer $0.5-1.0\text{ g/kg}$ IV bolus over 15-30 minutes through a dedicated in-line filter.
     • Mechanisms: Immediate plasma expansion decreases blood viscosity and induces reflex cerebral vasoconstriction within minutes, followed by delayed osmotic diuresis within 30-60 minutes.
     • Monitoring & Risks: Mannitol causes profound diuresis, hypovolemia, arterial hypotension, and prerenal azotemia. Serum osmolality and osmolar gap must be monitored closely:

$\text{Calculated Osm} = 2 \times [\text{Na}^+] + \frac{[\text{Glucose}]}{18} + \frac{[\text{BUN}]}{2.8}$ $\text{Osmolar Gap} = \text{Measured Osm} - \text{Calculated Osm}$

Tier 2: Second-Line Interventions for Refractory Elevations

1. Neuromuscular Blockade: Administer a continuous infusion of a non-depolarizing neuromuscular blocking agent (e.g., cisatracurium) to abolish shivering, posturing, and ventilator dyssynchrony. Deep sedation (RASS -5) is mandatory prior to initiating chemical paralysis.
2. Controlled Temporary Hyperventilation: Titrate mechanical ventilation to achieve a target $\text{PaCO}_2$ of $30-35\text{ mmHg}$.
   • Mechanism: Hypocapnia alkalinizes the CSF and cerebral perivascular space, causing potent cerebral arteriolar vasoconstriction that shrinks cerebral blood volume ($CBV$) and rapidly reduces ICP.
   • Strict Precautions: Hyperventilation is strictly a temporary rescue bridge while definitive therapies are prepared. Never hyperventilate to $\text{PaCO}_2 < 30\text{ mmHg}$ or maintain hyperventilation beyond a few hours; severe vasoconstriction causes critical cerebral hypoperfusion, severe cellular ischemia, and secondary infarction.
3. MAP Augmentation: Titrate norepinephrine infusions to defend a CPP between $60-70\text{ mmHg}$ against escalating ICP.

Tier 3: Third-Line Interventions for Refractory Intracranial Hypertension

1. Barbiturate Coma: High-dose pentobarbital ($10\text{ mg/kg}$ IV over 30 minutes, followed by $5\text{ mg/kg/h} \times 3\text{ hours}$, then maintenance infusion of $1-2\text{ mg/kg/h}$) or thiopental.
   • Mechanism: Barbiturates profoundly depress cerebral metabolism ($CMRO_2$) and cerebral blood flow, contracting blood volume.
   • Titration: Continuous EEG (cEEG) monitoring is mandatory, titrating the infusion to burst suppression (target 1 burst per $10-20\text{ seconds}$ or $3-5\text{ bursts/minute}$).
   • Complications: Barbiturates induce profound myocardial depression, peripheral vasoplegia, refractory hypotension, paralytic ileus, and immunosuppression. Invasive arterial line monitoring and aggressive vasopressor infusions are required.
2. Moderate Therapeutic Hypothermia ($32.0-34.0^\circ\text{C}$): Reduces $CMRO_2$ by $\approx 7\%$ per $1^\circ\text{C}$ decrease. Highly prone to complications including coagulopathy, malignant arrhythmias, electrolyte shifts, and severe infections. In Eurotherm3235 (2015), hypothermia of $32\text{--}35^\circ\text{C}$ as stage-2 ICP therapy lowered ICP but worsened functional outcome, and POLAR (2018) found no benefit from early prophylactic hypothermia; it is now reserved for refractory cases.
3. Surgical Decompressive Craniectomy: Removal of a large osseous bone flap with duraplasty to provide physical decompression for swollen brain tissue.

---

Surgical Decompressive Craniectomy: The DECRA vs. RESCUEicp Evidence

The role of decompressive craniectomy in severe traumatic brain injury has been defined by two landmark multicenter randomized clinical trials:

1. The DECRA Trial (NEJM 2011)

• Study Design: Evaluated early, secondary bifrontal decompressive craniectomy vs. medical therapy in patients with severe diffuse TBI who developed moderate, early refractory intracranial hypertension (ICP $> 20\text{ mmHg}$ for $> 15\text{ minutes}$ within a 1-hour window) despite Tier 1 medical management.
• Outcomes: Bifrontal craniectomy rapidly lowered ICP and reduced mechanical ventilation duration and ICU length of stay. However, at 6 months, patients in the craniectomy group had significantly worse functional neurological outcomes on the Extended Glasgow Outcome Scale (GOSE) compared to medical therapy (unfavorable outcome $70\%$ vs. $51\%$, odds ratio 2.21, $p=0.02$).
• Conclusion: Early bifrontal decompressive craniectomy for mild-to-moderate refractory ICP is not recommended because it does not improve functional recovery and increases disability.

2. The RESCUEicp Trial (NEJM 2016)

• Study Design: Evaluated secondary decompressive craniectomy (either unilateral frontotemporoparietal hemicraniectomy for focal lesions or bifrontal craniectomy for diffuse injury) vs. continued medical therapy (including barbiturate coma) in severe TBI patients with severe, sustained refractory intracranial hypertension (ICP $> 25\text{ mmHg}$ for $1\text{ to }12\text{ hours}$ refractory to Tier 1 and Tier 2 therapies).
• Outcomes: Secondary decompressive craniectomy resulted in a dramatic reduction in 6-month mortality ($26.9\%$ in the surgical group vs. $48.9\%$ in the medical group, $p < 0.001$).
• The Critical Trade-Off: The survival advantage was accompanied by a significant shift into surviving states with severe disability: at 6 months, vegetative survival was higher in the surgical group ($8.5\%$ vs. $2.1\%$) as was lower severe disability ($21.9\%$ vs. $14.4\%$). At 6 months, upper severe disability or better occurred in $42.8\%$ vs. $34.6\%$ (not significant); at 12 months this favorable outcome was $45.4\%$ vs. $32.4\%$.
• Conclusion: Decompressive craniectomy is a life-saving rescue procedure that averts death from herniation in refractory intracranial hypertension, but clinicians and surrogate decision-makers must recognize that survival often carries high rates of severe functional dependence.